老百姓121212016-07-27 11:32
$REXAHN PHARMACEUTICALS INC(RNN)$
The size of the gemcitabine resistant market (gemcitabine resistant pancreatic and bladder cancers) is approximately $4-8 billion per year. Initially RX-3117 may be used in patients that have already become resistant to gemcitabine. Howe...查看全文
深思远见2015-08-20 21:46
$REXAHN PHARMACEUTICALS INC(RNN)$近期评级信息如下:
20150814 MLV & Co. 重申相同投资评价, 评级:买入, 目标价:$1.25
更多分析和资讯,请关注微-信-公-众-号 stock_tong查看全文
割资本主义羊毛2015-04-20 04:50
$REXAHN PHARMACEUTICALS INC(RNN)$ 一家上市公司堂而皇之将一篇SA吹票文放到公司官网上,这是怎样的行为?[呵呵傻逼]
网页链接查看全文
疑夕2015-03-15 21:58
$REXAHN PHARMACEUTICALS INC(RNN)$ The company's Archexin is just a throwaway vamped up with new paint.查看全文
$Rexahn制药(RNN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-06 AccNo: 0001140361-19-019932 Size: 5 MB 网页链接
$Rexahn制药(RNN)$ 8-K - Current report Filed: 2019-08-29 AccNo: 0001140361-19-015750 Size: 34 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Rexahn制药(RNN)$ 8-K - Current report Filed: 2019-08-29 AccNo: 0001140361-19-015801 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Rexahn制药(RNN)$ 8-K - Current report Filed: 2019-08-07 AccNo: 0001140361-19-014411 Size: 120 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Rexahn制药(RNN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-07 AccNo: 0001140361-19-014413 Size: 6 MB 网页链接
$Rexahn制药(RNN)$ CERT - Filed: 2019-06-10 AccNo: 0001354457-19-000304 Size: 125 KB 网页链接
$Rexahn制药(RNN)$ 8-K - Current report Filed: 2019-06-07 AccNo: 0001140361-19-010648 Size: 37 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$Rexahn制药(RNN)$ 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities Filed: 2019-06-07 AccNo: 0001140361-19-010682 Size: 16 KB 网页链接
$Rexahn制药(RNN)$ 8-A12B - Registration of securities [Section 12(b)] Filed: 2019-06-07 AccNo: 0001140361-19-010684 Size: 24 KB 网页链接
$Rexahn制药(RNN)$ 8-K - Current report Filed: 2019-05-29 AccNo: 0001140361-19-009949 Size: 44 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and...